Ann Woolcock’S Work

Total Page:16

File Type:pdf, Size:1020Kb

Ann Woolcock’S Work Woolcock, Ann Janet 1937-2001 Respiratory Physician / Medical Scientist https://sydney.edu.au/medicine/museum/mwmuseum/extensions/MediaBank/MediaBankSh ow.php?mid=http://smp.sydney.edu.au/mediabank/|medmediabank|FMMUS134&imagex= 1000&imagey=600 ***** She was interviewed by Professor Jonathan Stone in 2000. The interview provides an excellent overview of Ann Woolcock’s work. See: https://www.science.org.au/learning/general-audience/history/interviews-australian- scientists/professor-ann-woolcock-1937-2001 . The summary is as follows: Professor Ann Woolcock was born in Reynella, South Australia in 1937. She graduated in medicine from the University of Adelaide and pursued postgraduate studies in respiratory medicine at the University of Sydney. Her MD thesis, awarded in 1967, was on the mechanical behaviour of the lungs in asthma. From 1966 to 1968 she worked at McGill University in Canada then returned to the University of Sydney to continue her work on asthma. Her research in asthma and epidemiology showed that asthma was caused by allergens but that there is a genetic component. In 1989, she wrote, with others, the world's first national guidelines for asthma management, the Australian Asthma Management Plan. In 1984 Professor Woolcock was appointed to a personal chair of Respiratory Medicine. She founded the Institute of Respiratory Medicine, based at the Royal Price Alfred Hospital in Sydney, and opened in 1985. The Institute was renamed the Woolcock Institute of Medical Research in her memory in August 2002. Beginnings: from home through university The move into research Asthma research: the shape of things to come Terrific productivity Epidemiological contributions Most of asthma is driven by allergy But not all allergic people get asthma 'Breakthroughs' for asthma? Real breakthroughs Forging a career Ceilings and supports Sharing good times in an academic family Taking a research institute into a cooperative research centre The interface between clinical work and research The future: asthma The future: the whole gamut in respiratory disease ***** The American Journal of Respiratory and Critical Care Medicine published the following appreciation in 2001: Home > All ajrccm Issues > Vol. 163, No. 5 | Apr 01, 2001 Peter Macklem https://doi.org/10.1164/ajrccm.163.5.16351 A star has been lost. Ann Janet Woolcock died, too young, on February 17, 2001. The enduring friendship she and I shared has been a privilege that has enriched my life enormously. She was one of the few people whom I trusted absolutely. I miss her. She succumbed to a 15-year battle against breast cancer. For a long time almost nobody outside of her immediate family and her doctors knew about it. She insisted that it be kept a secret. She first felt the fatal breast lump in the fall of 1986 while she was at a meeting in Singapore. Because she needed to talk to someone and I was there, I knew from the very beginning and knew how much the news upset her. After returning to Australia she had a mastectomy, followed by chemotherapy because there were positive lymph nodes. There followed a period of relative quiescence when we all hoped that the dread disease had been conquered. Alas, in 1997, a lymph node biopsy showed a recurrence. Ann knew what her future held for her. Rollo May has defined courage, not as the absence of fear, but as the ability to carry on in the face of despair. That fateful day in Singapore, I witnessed Ann's extraordinary courage for the first time. She was devastated by the uncertainty of her future. But to everybody else she acted as if everything was just fine, thank you. There was not a clue that she might have received a death sentence. Following the recurrence in 1997 she continued to act as if nothing was wrong. She knew she would eventually lose the battle, but in the face of this despair, she carried on. She remained active in international affairs. She competed for and won a large grant for a cooperative research center. She motivated and organized her colleagues and developed the research program for the CRC. A short time before her death her own personal research grant was renewed as were many others in the Institute for Respiratory Medicine that she founded. Talk about carrying on in the face of despair! She was a very courageous lady. Ann's professional life was devoted to improving the care of patients with respiratory disease. Indeed, when she created the Institute for Respiratory Medicine her philosophy for it was to focus on research with important practical applications to improve diagnosis, treatment, management, and quality of life, focusing particularly on individuals with asthma. She gathered around her a team of experts who could help her accomplish her goals. And accomplish them she did. She and her Institute became world leaders in the field of asthma research and management. She received many well deserved national and international honors. Among others, she was an Officer of the Order of Australia and one of the few women members of the Australian Academy of Sciences. To my mind, three of her achievements stand out above all others. In the early 60s, before she came to work with me, her first research showed that asthmatics could have severe hyperinflation with loss of lung elastic recoil, and that following appropriate therapy this could return to normal. These findings have been amply confirmed but never explained. How can the elastic properties of lungs, which most of us regard as immutable, change so quickly? This remains as much a mystery today as it was when Ann first reported it. Secondly, Ann showed that normal subjects had a plateau on the dose–response curve for smooth muscle agonists, whereas in asthma this plateau was lost. For me and many others this is the fundamental abnormality in asthma. The plateau on the dose–response curve protects normal subjects against excessive bronchoconstriction. The loss of the plateau is the only way that asthma can become a serious illness. She was, I believe, the first to develop individualized management plans for asthmatics. This is probably her greatest achievement and her idea has now been copied worldwide. It is probably the most important therapeutic advance for asthma since the introduction of steroids, and all it took was common sense, which Ann had in abundance. My daughter Jennifer, an artist who as a child knew Ann both in Montreal and later as an art student in Paris wrote “She was someone who had an enormous influence on me when I was little.” I doubt that Ann was aware of this, and I feel badly that she was not told. Her integrity, honesty, humility and generosity commanded more than respect. She was loved. During her last months she received more than 100 letters from around the world supporting her in her courageous fight. This profoundly touched her. Two and a half weeks before her death, Ann received an honorary degree from the University of Ferrara. During that celebration when I was with her for the last time I told her that all those letters showed how much she was loved. She appeared genuinely mystified. “Why should they love me,” she said, “what have I done for them?” Ann, in her humility, only realized late in her life how much she was loved. Thank heavens she died with that knowledge. This love was so strong it was palpable during the two speeches she gave when she received her degree. She was not strong enough to stand and gave her talks seated with a weakened voice. She may have been physically weak, but she was mentally as tough as ever. Her courage, just to be there, was heart rending and she received two of the most emotional standing ovations I have ever witnessed. Ann was a devoted wife and mother who had a close and loving relationship with her brothers and sister. Her family have suffered an irreplaceable loss. Our sympathies are with them. Her patients and indeed the worldwide community of asthmatics have lost their strongest advocate. Her colleagues in the Institute of Respiratory Medicine and in respiratory research the world over have lost an inspirational leader. The Meakins-Christie Laboratories has lost one of its most distinguished alumni. Ann was among my first research fellows and I have lost a scientific daughter. We have all lost a star. But the light she shed will not be extinguished. ***** More comprehensive and personal, is a biography authored by Babette Smith in Historical Records of Australian Science, 2014, 25, 313–336 See https://www.science.org.au/fellowship/fellows/biographical-memoirs, type ‘Woolcock’ into the ‘search by name’ space, and download the 24 page PDF. Page 1 is reproduced on the next page. On a personal note, the compiler of this article (PK), as a medical student, spent five weeks in New Guinea with Ann Woolcock as part of the University of Sydney survey team. We were in the Highlands – Baiyer River, Keglsugl and Goroka; it was January and February 1965. In those days Ann was known as ‘Annie’. The others in the team were Professor Blackburn, (Dr) Warren Arter – known as ‘Pud’, and medical student John Harris. .
Recommended publications
  • 9781920898359 Appendices R
    319 Appendix 1 University leadership Fellows of the Senate Students, Deputy Chair of Academic Staff or Alumni of the Board from 1980 Faculty from 1980 1978–1980 John Young 1978–1981 John Young 1986 Susan Dorsch 1979–1993 Katherine Georgouras 1986–1987 Ann Sefton 1983–1986 Andrew Refshauge 1991–1993 Alan Pettigrew 1986–1987 Diana Temple 1992–1996 James Lawrence 1987 Alan Cass 1996 Ann Sefton 1989 Anna Donald 1989 Tony Sara Senate Deputy Chancellor 1989 Eric Wegman from 1980 1990–1991 Natalie Smith 2004– Ann Sefton 1993–1995 Douglas Baird 1995–2002 Stephen Leeder 1996–2001 Michael Copeman 1997– Robin Fitzsimons 1997–2001 Peter Burrows 2001– Ann Sefton 2005– Michael Copeman 320 Appendix 2 Deans of the Faculty of Medicine from 1980 1974 –1989 Richard S Gye 1989 –1996 John Atherton Young 1997–2002 Stephen Leeder 2003 – Andrew Coats Appendix 3 Current Emeritus Professors Barry Baker John Little Tony Basten William McCarthy Geoffrey Berry James McLeod Charles Blackburn Russell Meares Charles Bridges-Webb Gerald Milton Neil Buchanan Kim Oates Peter Castaldi Murray Pheils John Chalmers Wai-On Phoon Patrick De Burgh Thomas Reeve Susan Dorsch Douglas Saunders Hans Freeman Ann Sefton Kerry Goulston Ainslie Sheil Richard Gye Frederick Stephens Akos Gyory Michael Taylor Noel Hush Thomas Taylor Gordon Johnson Stewart Truswell Charles Kerr John Turtle James Lawrence Robert Wake 321 Appendix 4 Professors appointed or promoted 1980–2005 1980 W Cramond 1989 Nicholas Hunt 1994 Leigh Delbridge 1980 Graeme Johnston 1989 John Sutton 1994 Ian Frazer 1980 Philip
    [Show full text]
  • BASIL HETZEL INSTITUTE RESEARCH REPORT Translational Health Research Creating Positive Outcomes for Thousands of South Australians DR BASIL S HETZEL 1922–2017
    BASIL HETZEL INSTITUTE RESEARCH REPORT Translational health research creating positive outcomes for thousands of South Australians DR BASIL S HETZEL 1922–2017 The research community at The Queen Elizabeth Hospital (TQEH) was saddened by the death of Dr Basil S Hetzel AC on February 4 2017. Basil was appointed as the first Michell Professor of Medicine at the University of Adelaide, TQEH in 1959. He will be remembered around the world for his pioneering work on iodine deficiencies and thyroid disease. Since visiting the highland villages of Papua We thank THRF staff for New Guinea in 1964, Basil became an international advocate for providing content and photos iodine supplementation and ultimately co-founded the International for this report. We also thank Council for Control of Iodine Deficiency Disorders (ICCIDD) which the Royal Australasian College had its inaugural meeting in Kathmandu, Nepal in 1986. Today this of Surgeons and the Adelaide organisation is known as the Iodine Global Network (IGN). G-TRAC Centre for allowing us to use some of their images. In 2001 the long-standing research activities of TQEH were renamed Additional photos used in as the Basil Hetzel Institute. Basil was a proud supporter of all this report were taken by research endeavours and regularly attended the annual TQEH Andrew Beveridge (ASB Research Day. In addition he was a great mentor and active supporter Creative), Basil Popowycz of research and of people doing research. and Rebecca Anderson. The photo on the front cover of this report was taken at the unveiling of the portrait of Basil by South Australian artist Avril Thomas.
    [Show full text]
  • TSANZ Ann Woolcock Young Investigator Awards Oral
    bs_bs_banner Respirology (2016) 21 (Suppl. 2), 21–100 doi: 10.1111/resp.12754 TO 002 Nurses SIG Symposium Part 1 Oral Presentations NURSES SUPPORT DELIVERY OF SPIROMETRY TO TOP END RESPIRATORY OUTREACH CLINICS: A REVIEW OF THE TO 001 SERVICE EXPANSION AND DEVELOPMENT OF SYSTEMS HARWOOD S, O’LOUGHLAN M Royal Darwin Hospital INCIDENCE AND OUTCOMES OF ACUTE RESPIRATORY ILLNESS (ARI) WITH COUGH IN URBAN INDIGENOUS CHILDREN Introduction/Aim: Chronic lung conditions are a major cause of morbidity and mortality among Indigenous Australians in remote communities across HALL K1, CHANG A1,2,3,ANDERSONJ4, ARNOLD D1, KEMP A4,O’GRADY K1 the Northern Territory (NT) Top End. The Royal Darwin Hospital (RDH) respi- 1Queensland University of Technology, 2Menzies School of Health Research, ratory service commenced on site in 2010 and identified a lack of spirometry Charles Darwin University, Darwin, 3Department of Respiratory Medicine, testing at remote community health clinics. Remote outreach clinic planning Queensland Children’s Health Services, Brisbane, 4Murri Health Group, prioritized the provision of nurse led spirometry testing so essential for access Caboolture to early detection, diagnosis and monitoring of chronic lung conditions. We performed a review of the service to monitor the expansion including spirom- etry numbers and systems used for the performance and recording of spirom- Introduction: Studies suggest that 10% of children with an ARI have etry tests obtained from a cohort of 408 clients from 21 remote clinics. persistent cough at day 21. There are no studies in Indigenous children who Methods: have a high risk of chronic lung disease. We aimed to identify the incidence • We performed a retrospective review of spirometry numbers from 21 and outcomes of ARI with cough as a symptom in urban Indigenous children.
    [Show full text]
  • Biennial Report
    Woolcock Institute of Medical Research BIENNIAL REPORT 2014 - 2015 Our work makes a difference to people’s lives www.woolcock.org.au The Woolcock Institute’s mission is to improve the respiratory and sleep health of all Australians through research, education, prevention and care. Woolcock Institute of Medical Research BIENNIAL REPORT 2014 - 2015 CONTENTS Who We Are Our Vision 4 Our Aspiration 4 Our History 4 Mission Statement 4 Affiliations 5 Chairman’s Report 6 Executive Director’s Report 8 Our Research Airway Physiology and Imaging 11 Allergen and Upper Airways 13 Clinical Management 14 Respiratory and Environmental Epidemiology 18 Woolcock Institute in Vietnam 21 Respiratory Cellular and Molecular Biology 22 Respiratory Technology 23 Sleep and Circadian 25 Ann Woolcock Lecture 28 Education 28 Our Clinics 29 Woolcock Workplace Gender Equality 30 New Initiatives for Research Centre for Lung Cancer Research 30 Woolcock Centre of Research Excellence in Emphysema 30 Research Leaders 31 Distinguished Alumni 35 Our Media Profile 37 Fundraising 37 Governance 38 Board of Directors 39 Committees 42 Our Financials 43 Our Publications 45 Our Contacts 60 WHO WE ARE Our Vision Mission Statement A better quality of life for people with sleep, breathing and The Woolcock Institute of Medical Research is lung disorders and their families. Australia’s leading respiratory and sleep research organisation. Our Aspiration With a world-class network of specialised researchers, we To build the Woolcock Institute into the pre-eminent centre deal with the causes, prevention, diagnosis and treatment for sleep and respiratory research and translation in of respiratory disease and sleep disorders.
    [Show full text]
  • Message from the New President
    Öïì®±³¬ Î﮲ ¨Äåãåíâåò¬ ²°°´© Editor : Yoshinosuke Fukuchi Associate Editors : Takashi Horie, J. Patrick Barron, H. Sato Cochrane Message from the New President It was a great honor to assume the presidency of the APSR following Professor Wah Kit Lam who made such outstanding achievements during his two- year term 2002-2004. He is an impeccable role model for me to follow as a highly motivated leader of a growing society. I learned many lessons from him through my collaboration as Secretary General and President-elect. His many achievements included innovative proposals, rapid and efficient decision- making, and an unsurpassed sense of balance at any meeting he chaired. It is my sincere wish that I work with comparable effi ciency. I am fully determined to keep the activity of the APSR at the high standard it has been for the last two years. I am very fortunate to have two eminent respirologists working with me for the next two years. The new Secretary General, Professor Norbert Berend, is a director of the Ann J Woolcock Institute of Respiratory Medicine and Professor of Medicine at the University of Sydney. He was associated with Professor Woolcock for a long time and naturally became involved with the running the APSR at an early stage of its development. He served as chairperson of the Strategic Planning Committee (SPC) and became truly instrumental in revising the Charter & Bylaws of the Society. He was also responsible for drafting various memos for en-bloc membership of the Japanese Respiratory Society (JRS) now ratified by both parties. He will remain as chair of the SPC in addition to serving as Secretary General.
    [Show full text]
  • Factor Matters NSW
    Haemophilia Foundation Factor Matters NSW Published by HFNSW November 2016 Volume 34 HAMISH WONDERS ABOUT MYABDR DATA? MORE NEW MEMBERS, HEAR FROM ONE... THOUSANDS ATTEND WFH ORLANDO 2016 INCLUDING SAM LINNENBANK & HFA PRESIDENT, WHO REPRESENTED AUSTRALIA AT WFH CONGRESS ALL OF THE ABOVE PLUS A MAJOR FEATURE OUR PATRON ON PROFESSOR BLACKBURN… & MORE! CONTENTS About Us In This Issue HFNSW is a member driven not for profit organisation p. 2 - About Us & In This Issue that provides support programs and advocacy for the p. 3 - From the President NSW bleeding disorders community, their families and carers. While specialist doctors and nurses provide p. 4-7 Prof Blackburn Remembered world class medical and social care for our members, p. 8 - MyABDR... The Data Management our mandate is to support the full range of other Back Story important things for the bleeding disorder community p. 9 - Alvin at Orlando WFH World Congress ‘16 such as: community participation, physical & emotional p. 10 - A New Member Shares... support, advocacy, education and financial assistance p. 11-12 HFNSW’s Picture This... to members, their families and carers. Including Our AGM! p. 13 - News & Just Post-It HFNSW Committee p. 14 - Membership Form Prof Kevin Rickard, AM, RFD - PATRON p. 15 - Haemophilia Centres & HFNSW Dan Credazzi - President Dr Garry Lynch - Vice-president On the cover: Hamish wonders about Myabdr Data? Paul Bedbrook - Treasurer More New Members, hear from one. Craig Haran - Member Thousands attend WFH Orlando 2016 Hamish Robinson - Member Including Sam Linnenbank & HFA President Leonie Mudge - RPA Haemophilia Social Worker who represented Australia at WFH Congress.
    [Show full text]
  • Biennial Report 2018
    Woolcock Institute of Medical Research BIENNIAL REPORT 2018 + 2019 Our work makes a difference to people’s lives www.woolcock.org.au 1 CONTENTS About Us 4 Who We Are 4 Our History 4 Our Vision 4 Our Aspiration 4 Our Values 4 Woolcock named world’s best in field 4 Partnerships and Affiliations 5 Key Priorities 5 Strategic Objectives 5 Our Organisation 6 Chairman’s Report 7 Executive Director’s Report 9 Research Leaders 11 Our Distinguished Alumni 16 Our Research Groups 19 Airway Physiology and Imaging 20 Clinical Management 22 Respiratory and Environmental Epidemiology 23 Respiratory Cellular and Molecular Biology 25 Respiratory Technology 26 Sleep and Circadian Research Group 27 Co-operative Research Centre (CRC) for Alertness, Safety and Productivity 27 Health Psychology 27 Neurobiology 27 Epidemiology/Clinical Trials 27 Cardio-metabolic 28 Respiratory Failure 28 Woolcock Emphysema Centre 34 Woolcock Institute in Vietnam 35 Woolcock Centre for Lung Cancer Research and Lung Cancer Research Network 36 Ann Woolcock Lecture 37 Education 37 Our Clinic 38 In the Media 39 Committees 41 Financial Performance 42 Board of Directors 45 Publications 49 2018 49 2019 57 2 Portrait of Professor Ann Woolcock. Artist: Anne Spudvilas (2002) 3 ABOUT US WHO WE ARE OUR VALUES Currently ranked as the leading sleep and respiratory RESPECT research institute in Australia, the Woolcock is a globally renowned network of researchers and clinicians who deal • We support open, respectful discussion, effective with the causes, prevention, diagnosis and treatment of communication, transparent decision making and respiratory disease and sleep disorders. productive internal governance practices OUR HISTORY • We always show respect for staff, patients, families and carers as well as referring clinicians The late Professor Ann Woolcock (1937–2001) established the Institute in Sydney in 1981 with a vision to become EXCELLENCE Australia’s centre of excellence for respiratory research.
    [Show full text]
  • Biennial Report
    Woolcock Institute of Medical Research BIENNIAL REPORT 2016 + 2017 Our work makes a difference to people’s lives www.woolcock.org.au 1 The Woolcock Institute’s mission is to improve the respiratory and sleep health of all Australians through research, education, prevention and care. BIENNIAL REPORT 2016 + 2017 CONTENTS Introduction 5 About Us 5 Our Organisation 6 Reports 7 Chairman’s Report 7 Executive Director’s Report 8 Research Leaders 9 Distinguished Alumni 13 Our Research Groups 16 Airways Physiology and Imaging 17 Clinical Management 19 Emphysema Centre 23 Woolcock Institute in Vietnam 25 Respiratory and Environmental Epidemiology 26 Respiratory Cellular and Molecular Biology 28 Respiratory Technology 30 Sleep and Circadian 31 Centre for Lung Cancer Research and Lung Cancer Research Network 36 Ann Woolcock Lecture 37 Education 37 Our Clinics 38 Committees 39 Financial Performance 40 Board of Directors 42 Our Publications 45 3 BIENNIAL REPORT 2016 + 2017 ABOUT US OUR VISION OUR AFFILIATIONS The Woolcock Institute operates as an independent company A better quality of life for people with sleep, breathing limited by guarantee and is governed by a distinguished and lung disorders and their families. board made up of outstanding researchers, leaders from OUR MISSION industry and commerce, health system experts and senior university administrators. The Woolcock Institute of Medical Research is Australia’s leading respiratory and sleep research organisation. We have an Affiliation Agreement with The University of Sydney. We are a member of Sydney Research — an OUR HISTORY alliance of medical research institutes; Sydney Local The late Professor Ann Woolcock (1937–2001) Health District and The University of Sydney and we also established the Institute in Sydney in 1981 with a vision have Memorandums of Understanding with University of to become Australia’s centre of excellence for respiratory Technology, Sydney and The University of NSW that all research.
    [Show full text]